Physician profile
Anthony E Caglia
NPI 1831420512
$2,828.72
in general payments reported to CMS, 2019-2025
16 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $90.37 · 2021: $306 · 2022: $280 · 2023: $1,036 · 2024: $779 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,152.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $716.53 | 2023-2025 | Skyrizi, Rinvoq |
| E.R. Squibb & Sons, L.L.C. | $488.68 | 2021-2025 | Sotyktu |
| Incyte Corporation | $314.57 | 2023-2025 | Opzelura |
| Leo Pharma INC. | $206.26 | 2023-2025 | Adbry |
| Ucb, INC. | $198.92 | 2023-2024 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $181.89 | 2023-2024 | Zoryve |
| Lilly USA, LLC | $141.54 | 2022-2025 | Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $139.80 | 2020-2025 | |
| Janssen Biotech, INC. | $128.60 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $119.60 | 2020-2025 | Cabtreo |
| Mayne Pharma Commercial LLC | $72.49 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.19 | 2022-2025 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $22.68 | 2023 | Dupixent |
| Vyne Pharmaceuticals INC. | $19.45 | 2020 | |
| Journey Medical Corporation | $18.61 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.91 | 2023 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Caglia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.